Potential acquirers interest are driven internally—strategy, corporate priorities, M&A appetite, more than externally—target company’s technology or pre-commercial products. While this should be straight forward, Boards, stockholders, and management teams can spend too much time just polishing the sell-side story, as they have envisioned it, rather than also view it from the position of named, specific potential acquirers.… Read More Selling a Pre-commercial Diagnostic or Life Science Company